PT - JOURNAL ARTICLE ED - , TI - SKP2 Is a Potential Cancer Drug Target AID - 10.1158/2159-8290.CD-RW2013-175 DP - 2013 Oct 01 TA - Cancer Discovery PG - OF30--OF30 VI - 3 IP - 10 4099 - http://cancerdiscovery.aacrjournals.org/content/3/10/OF30.short 4100 - http://cancerdiscovery.aacrjournals.org/content/3/10/OF30.full SO - CANCER DISCOVERY2013 Oct 01; 3 AB - A selective inhibitor of SKP2 E3 ligase impairs cancer stem cell self-renewal and tumor growth.